Brett D Atwater1, W Schuyler Jones2, Zak Loring2, Daniel J Friedman3. 1. Division of Cardiology, Duke University School of Medicine, Durham, NC, USA; Division of Cardiology, Durham VA Medical Center, Durham, NC, USA. Electronic address: brett.atwater@duke.edu. 2. Division of Cardiology, Duke University School of Medicine, Durham, NC, USA; Division of Cardiology, Durham VA Medical Center, Durham, NC, USA. 3. Division of Cardiology, Yale University School of Medicine, New Haven, CT, USA.
Abstract
BACKGROUND: Some patients with ongoing heart failure symptoms after treatment with cardiac resynchronization therapy (CRT) demonstrate QRS prolongation during exercise. We investigated whether the optimal CRT pacing configuration changes during dobutamine stress. METHODS: Seven patients undergoing CRT implantation underwent invasive LV dP/dTmax measurement during CRT pacing in 10 configurations to determine the optimal baseline pacing configuration (OPC). Measurements were repeated during dobutamine infusion. Differences in mean LV dP/dTmax between pacing configurations were compared. RESULTS: Baseline OPC differed from stress OPC in 6/7 patients. The mean (SD) LV dP/dTmax obtained during dobutamine infusion was 1140 (377) mmHg/s in AAI pacing, 1458 (448) mmHg/s in the baseline OPC, and 1656 (435) mmHg/s in the dobutamine OPC (p < 0.001 for differences). The mean increase in LV dP/dTmax obtained by changing from baseline OPC to dobutamine OPC during dobutamine infusion was 197 (338) mmHg/s (13%). The QRS duration, QRS morphology, QLV and QRV intervals did not change significantly during dobutamine infusion (all P > 0.05). CONCLUSIONS: The optimal CRT pacing configuration changes during dobutamine infusion while LV and RV activation timing does not. Further studies investigating the usefulness of automated dynamic changes to CRT pacing configuration according to physiologic condition may be warranted.
BACKGROUND: Some patients with ongoing heart failure symptoms after treatment with cardiac resynchronization therapy (CRT) demonstrate QRS prolongation during exercise. We investigated whether the optimal CRT pacing configuration changes during dobutaminestress. METHODS: Seven patients undergoing CRT implantation underwent invasive LV dP/dTmax measurement during CRT pacing in 10 configurations to determine the optimal baseline pacing configuration (OPC). Measurements were repeated during dobutamine infusion. Differences in mean LV dP/dTmax between pacing configurations were compared. RESULTS: Baseline OPC differed from stress OPC in 6/7 patients. The mean (SD) LV dP/dTmax obtained during dobutamine infusion was 1140 (377) mmHg/s in AAI pacing, 1458 (448) mmHg/s in the baseline OPC, and 1656 (435) mmHg/s in the dobutamine OPC (p < 0.001 for differences). The mean increase in LV dP/dTmax obtained by changing from baseline OPC to dobutamine OPC during dobutamine infusion was 197 (338) mmHg/s (13%). The QRS duration, QRS morphology, QLV and QRV intervals did not change significantly during dobutamine infusion (all P > 0.05). CONCLUSIONS: The optimal CRT pacing configuration changes during dobutamine infusion while LV and RV activation timing does not. Further studies investigating the usefulness of automated dynamic changes to CRT pacing configuration according to physiologic condition may be warranted.
Authors: Wouter M van Everdingen; Alwin Zweerink; Maarten J Cramer; Pieter A Doevendans; Uyên Châu Nguyên; Albert C van Rossum; Frits W Prinzen; Kevin Vernooy; Cornelis P Allaart; Mathias Meine Journal: Circ Arrhythm Electrophysiol Date: 2018-03
Authors: Osman Can Yontar; Mehmet Birhan Yilmaz; Kenan Yalta; Alim Erdem; Izzet Tandogan Journal: Arq Bras Cardiol Date: 2010-11-12 Impact factor: 2.000
Authors: Michael R Gold; Angelo Auricchio; John D Hummel; Michael C Giudici; Jiang Ding; Bruce Tockman; Julio Spinelli Journal: Heart Rhythm Date: 2005-04 Impact factor: 6.343
Authors: Jagmeet P Singh; Dali Fan; E Kevin Heist; Chrisfouad R Alabiad; Cynthia Taub; Vivek Reddy; Moussa Mansour; Michael H Picard; Jeremy N Ruskin; Theofanie Mela Journal: Heart Rhythm Date: 2006-08-10 Impact factor: 6.343
Authors: Tomas Roubicek; Dan Wichterle; Pavel Kucera; Pavel Nedbal; Jindrich Kupec; Jana Sedlakova; Jan Cerny; Jan Stros; Josef Kautzner; Rostislav Polasek Journal: Circ Arrhythm Electrophysiol Date: 2015-09-03
Authors: Cecilia Linde; William T Abraham; Michael R Gold; Martin St John Sutton; Stefano Ghio; Claude Daubert Journal: J Am Coll Cardiol Date: 2008-11-07 Impact factor: 24.094
Authors: Arthur J Moss; W Jackson Hall; David S Cannom; Helmut Klein; Mary W Brown; James P Daubert; N A Mark Estes; Elyse Foster; Henry Greenberg; Steven L Higgins; Marc A Pfeffer; Scott D Solomon; David Wilber; Wojciech Zareba Journal: N Engl J Med Date: 2009-09-01 Impact factor: 91.245
Authors: Brett D Atwater; Kasper Emerek; Zak Loring; Christoffer Polcwiartek; Kevin P Jackson; Daniel J Friedman Journal: HeartRhythm Case Rep Date: 2020-05-07